Del Donno M, Bittesnich D, Chetta A, Olivieri D, Lopez-Vidriero M T
Istituto di Clinica delle Malattie dell'Apparato Respiratorio, Università di Parma, Parma, Italy.
Chest. 2000 Oct;118(4):1142-9. doi: 10.1378/chest.118.4.1142.
Mucociliary clearance (MCC) is one of the most important nonspecific defense mechanisms of the respiratory tract, and its impairment is a well-documented feature of chronic respiratory diseases, including asthma. In vitro and in vivo data suggest that several inflammatory mediators influence the mucociliary apparatus. Epithelial damage and functional abnormalities have been described in bronchial asthma, along with changes in mucus-secreting cells and the chemical and rheological properties of airway fluid. Although the mechanisms of MCC impairment in asthma are not clearly understood, data in the recent literature suggest that airway inflammation plays a major role. In this article, we review studies on MCC alterations in light of up-to-date findings on pathogenetic mechanisms in asthma.
黏液纤毛清除功能(MCC)是呼吸道最重要的非特异性防御机制之一,其功能受损是包括哮喘在内的慢性呼吸道疾病的一个有充分文献记载的特征。体外和体内数据表明,多种炎症介质会影响黏液纤毛装置。支气管哮喘中已描述了上皮损伤和功能异常,以及黏液分泌细胞的变化和气道液体的化学及流变学特性的改变。尽管哮喘中MCC受损的机制尚不清楚,但近期文献中的数据表明气道炎症起主要作用。在本文中,我们根据哮喘发病机制的最新研究结果,对MCC改变的相关研究进行综述。